11/27
06:40 pm
imcr
Immunocore (IMCR) Q2 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Immunocore (IMCR) Q2 2025 Earnings Call Transcript [Yahoo! Finance]
11/18
09:00 am
imcr
The Galien Foundation Announces 2025 Prix Galien Bridges Awards Nominees for "Best Bridge-Builder Institution," "Best Biomedical Product," "Best Medical Technology/AI Advances in Human Health," "Best Product for Rare/Orphan Diseases," and "Best Public Sec
Low
Report
The Galien Foundation Announces 2025 Prix Galien Bridges Awards Nominees for "Best Bridge-Builder Institution," "Best Biomedical Product," "Best Medical Technology/AI Advances in Human Health," "Best Product for Rare/Orphan Diseases," and "Best Public Sec
11/10
01:48 pm
imcr
Immunocore (NASDAQ:IMCR) had its price target raised by analysts at Morgan Stanley from $34.00 to $36.00. They now have an "equal weight" rating on the stock.
Low
Report
Immunocore (NASDAQ:IMCR) had its price target raised by analysts at Morgan Stanley from $34.00 to $36.00. They now have an "equal weight" rating on the stock.
11/10
07:00 am
imcr
Immunocore to present at upcoming investor conferences
Medium
Report
Immunocore to present at upcoming investor conferences
11/9
08:23 am
imcr
Immunocore Holdings plc (NASDAQ:IMCR) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]
Low
Report
Immunocore Holdings plc (NASDAQ:IMCR) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]
11/8
01:12 am
imcr
Low
Report
11/7
11:28 pm
imcr
Immunocore: Continuing To Improve The Bottom Line, But Needing A Big Catalyst [Seeking Alpha]
Low
Report
Immunocore: Continuing To Improve The Bottom Line, But Needing A Big Catalyst [Seeking Alpha]
11/7
08:00 am
imcr
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
Medium
Report
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
11/6
07:00 am
imcr
Immunocore reports third quarter financial results and provides a business update
Low
Report
Immunocore reports third quarter financial results and provides a business update
11/4
05:49 am
imcr
Immunocore (NASDAQ:IMCR) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Low
Report
Immunocore (NASDAQ:IMCR) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
10/31
07:19 am
imcr
Immunocore (NASDAQ:IMCR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
Low
Report
Immunocore (NASDAQ:IMCR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
10/22
01:57 pm
imcr
Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Medium
Report
Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
10/8
12:25 pm
imcr
Immunocore (NASDAQ:IMCR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Immunocore (NASDAQ:IMCR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
9/18
09:41 am
imcr
Immunocore (NASDAQ:IMCR) had its "neutral" rating reaffirmed by analysts at Guggenheim.
Low
Report
Immunocore (NASDAQ:IMCR) had its "neutral" rating reaffirmed by analysts at Guggenheim.
9/16
12:10 pm
imcr
Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
Low
Report
Quetzal Therapeutics Appoints Dr. Shaad Abedin as Chief Medical Officer
9/14
08:39 am
imcr
Assessing Immunocore Holdings (NasdaqGS:IMCR) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Immunocore Holdings (NasdaqGS:IMCR) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
9/10
03:30 am
imcr
Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer
Low
Report
Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer
9/10
03:30 am
imcr
Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer
Low
Report
Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer
9/10
02:19 am
imcr
Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday 17 September 2025 [Yahoo! Finance]
Low
Report
Zelluna Announces Investor Forum on Science & Strategy to be held on Wednesday 17 September 2025 [Yahoo! Finance]
9/6
06:47 am
imcr
Immunocore (NASDAQ:IMCR) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Immunocore (NASDAQ:IMCR) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.